Current usage of stereotactic body radiotherapy for oligometastatic prostate cancer in Korea: patterns of care survey (KROG 19-08)

BACKGROUND: Growing evidence suggests that metastasis-directed therapy and/or prostate-directed therapy may benefit patients with oligometastatic prostate cancer (OMPC). Stereotactic body radiotherapy (SBRT) is increasingly used to treat oligometastases in various cancers. The purpose of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Bae, Sun Hyun, Jang, Won Il, Kang, Hyun-Cheol, Kim, Young Il, Kim, Yong Ho, Kim, Woo Chul, Lee, Hee Kwan, Kim, Jin Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422114/
https://www.ncbi.nlm.nih.gov/pubmed/34532428
http://dx.doi.org/10.21037/atm-21-1116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422114/
https://www.ncbi.nlm.nih.gov/pubmed/34532428
http://dx.doi.org/10.21037/atm-21-1116

Ejemplares similares